A Randomised, Placebo-controlled, Double-blind, Parallel Groups, Multinational, Multicentre Trial Assessing the Effect of Barusiban Administered Subcutaneously on the Day of Transfer on Implantation and Pregnancy Rates in IVF/ICSI Patients

Trial Profile

A Randomised, Placebo-controlled, Double-blind, Parallel Groups, Multinational, Multicentre Trial Assessing the Effect of Barusiban Administered Subcutaneously on the Day of Transfer on Implantation and Pregnancy Rates in IVF/ICSI Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Barusiban (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms BASIC
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 15 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record..
    • 23 Apr 2015 Planned End Date changed from 1 Apr 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
    • 25 Nov 2014 Planned End Date changed from 1 Nov 2014 to 1 Apr 2015, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top